Publication

A glimpse into the future of model-informed drug discovery and development

Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…

CertaraAugust 28, 2026

Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

CertaraAugust 28, 2026

Blog

Why pharmacometrics automation is the foundation of modern PK/PD

Pharmacometrics automation is reshaping PK/PD workflows. Explore five principles driving AI, cloud infrastructure, and model…

Sebastian KuechenmeisterAugust 28, 2026

Blog

The five drug development questions that bring sponsors to pharmacometrics

Sponsors rarely come to pharmacometrics because they need a model. They come with a development…

Rik de GreefAugust 24, 2026

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhDAugust 13, 2026

Blog

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Discover RsNLME's new MCP server: an AI assistant that understands both pharmacometric science and PML/R…

Arjen BosAugust 3, 2026

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

CertaraJuly 29, 2026

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

CertaraJuly 24, 2026

Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Matt Zierhut, PhD MBAJuly 23, 2026

Live Events

Phoenix Roadshow 2026 – Tokyo

CertaraJuly 21, 2026

Clinical Pharmacology

A glimpse into the future of model-informed drug discovery and development

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Why pharmacometrics automation is the foundation of modern PK/PD

The five drug development questions that bring sponsors to pharmacometrics

A model-informed approach to radioligand therapy dosing under Project Optimus

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

Important drug development questions that model-based meta-analysis answers

Phoenix Roadshow 2026 – Tokyo

Newsletter sign up

Quick links

Solutions

Contact